Background

Qualifications

B.Sc. 1984. Pharmacology, University of Edinburgh

M.B., Ch.B. 1987. University of Edinburgh

Ph.D. 1993. Neuropharmacology, University of Edinburgh

M.R.C.Psych. 1995

M.D. 2004. Newcastle University

F.R.C.Psych. 2007

 

Previous Positions

1988 - 1992: Wellcome Clinical Research Fellow, Department of Pharmacolgy, University of Edinburgh.

1992 - 1994: SHO, Lothian Psychiatric Training Rotation.

1994 - 1995: Registrar, South East Scotland Psychiatric Training Rotation.

1995 - 1999: Clinical Lecturer in Psychiatry, Department of Psychiatry, University of Newcastle upon Tyne.

Memberships

Member of the British Medical Association.
Member of the Medical and Dental Defence Union of Scotland.
Member of the British Association for Psychopharmacology.
Member of the Royal College of Psychiatrists.
Member of the British Neuroscience Association.
Member of the European College of Neuropsychopharmacology.
Member of the Society for Biological Psychiatry

Roles and Responsabilities

1998 - present:   Honorary Consultant Psychiatrist, Regional Affective Disorders Service, Northumberland Tyne and Wear NHS Foundation Trust 

2000 – 2003:      Royal College of Psychiatrists, EMI Working Group.

2000 – Present: Executive Committee Member, Special Interest Group in Psychopharmacology, Royal College of Psychiatrists.

2000 - 2006:      Newcastle, North Tyneside and Northumberland Mental Health (NHS) Trust, Drugs and Therapeutics Committee (Vice-Chairman from 2002 and Chair from 2004).

2001 - 2005:      Newcastle and North Tyneside Health Authority, Protocol Steering Group.

2001 - 2005:      Academic Secretary, Royal College of Psychiatrist, Northern and Yorkshire Division.

2002 - 2005:      Medical Research Council Advisory Board

2002:                  Health Service Ombudsman External Clinical Assessor

2003 - 2004:       Programme Director for Royal College of Psychiatrists Annual Meeting 2004

2004 – 2007:      Elected Council Member, British Association of Psychopharmacology

2005 - 2009:      Academic Secretary, Faculty of General and Community Psychiatry, Royal College of Psychiatrists

2007 – 2008:     Chair, Medicines Management Committee, Northumberland Tyne and Wear NHS Trust

2007 – 2011:     Honorary General Secretary and Education Officer, British Association for Psychopharmacology

2007 – Present: General Adult Psychiatry Higher Training Sub-Committee, Northern Deanery

2007 – Present: Ethics Committee, Faculty of Medical Sciences, Newcastle University

2007 – Present: Module Organiser, Cognitive Neuroscience and Psychiatric Illness, M.Res. Degree, Newcastle University

2008 – Present: Member, Mental Health Research Network Industry Adoption Committee

2008- Present: Member steering group Prescribing Observatory in Mental Health-UK Lithium audit

2008 – 2009:     Member National Specialist Commissioning Definition Sets Working Group – Lead on Complex and Treatment Refractory Mental Illnesses

2009 – 2010:     Royal College of Psychiatrists representative on a range of NICE HTAs

2010 – 2011:     Member, MRC Panel of Medical Research Foundation's mental Health Clinical research training fellowship programme

2010-Present:  Member, Organising Committee, Royal College of Psychiatrists’ International Congress: Brighton 2011; Liverpool 2012

2010-Present:  Associate Editor, Therapeutic Advances in Psychopharmacology

2011- Present: Member, European College of Neuropsychopharmacology Membership Committee 

Research

Research Interests

My interests are in the pathophysiology and treatment of affective disorders. In particular I am interested in the hypothalamic-pituitary-adrenal axis and the serotonergic system. I utilise a number of EEG techniques including cognitive event related potential recordings to study the neuropsychological impairment in psychiatric illness. In addition I have developed a putative method for examing serotonergic function in man that has been utilised to study depressed patients and the effects of cortisol on serontonergic function in healthy subjects.

Funding

I have previously been supported through a Wellcome Trust Clinical Research Fellowship and an MRC Clinician Scientist Fellowship. I have had grants from the Nuffield Foundation, Newcastle University Hospital Special Trustess and Industry.

Publications

• Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R, British Assoc Psychopharmacology. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 2015, 29(5), 459-525.
• Pariante CM, Alhaj HA, Arulnathan VE, Gallagher P, Hanson A, Massey AE, McAllister-Williams RH. Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: A study using EEG and cognitive testing. Psychoneuroendocrinology 2012, 37(5), 618-628.
• Vasudev K, Keown P, Gibb I, McAllister-Williams RH. Hematological Effects of Valproate in Psychiatric Patients What Are the Risk Factors?. Journal of Clinical Psychopharmacology 2010, 30(3), 282-285.
• Paton C, Barnes TRE, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones PB, McIntyre S. Lithium in bipolar and other affective disorders: Prescribing practice in the UK. Journal of Psychopharmacology 2010, 24(12), 1739-1746.
• McAllister-Williams RH, Baldwin DS, Haddad PM, Bazire S. The use of antidepressants in clinical practice: focus on agomelatine. Human Psychopharmacology: Clinical and Experimental 2010, 25(2), 95-102.
• McAllister-Williams R. Review: clinically important differences between antidepressants. Evidence-Based Mental Health 2009, 12(4), 107.
• Alhaj HA, McAllister-Williams RH. DHEA improves recollection and mood in healthy young men: an electrophysiological study. In: International Journal of Neuropsychopharmacology. 2004, Paris, France: Cambridge University Press.
• Alhaj HA, McAllister-Williams RH. Effects of DHEA on neuropsychological function, mood and salivary cortisol in healthy young men. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2004, Harrogate, UK: Sage Publications Ltd.
• McAllister-Williams RH. Electrophysiological examination of frontal and temporal function during performance of episodic memory tasks. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2004, Harrogate, UK: Sage Publications Ltd.
• McAllister-Williams RH, Marsh VR, Massey AE. Increased sensitivity of somatodendritic 5-HT1A autoreceptors in depression. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2004, Harrogate, UK: Sage Publications Ltd.
• Hsu FC, Massey AE, McAllister-Williams RH. Does hypercortisolaemia causes anterior cingulate cortex dysfunction in healthy volunteers? An event-related potential. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
• Alhaj HA, Massey AE, McAllister-Williams RH. Event-related brain potentials investigation of the effects of four-day, high-dose course of cortisol on the neural correlates of episodic memory. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
• Fairchild GF, Massey AE, Hsu FC, McAllister-Williams RH. Repeated cortisol administration attenuates 5-HT1A autoreceptor function in humans. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
• Fairchild GF, Massey AE, Hsu FC, McAllister-Williams RH. Repeated cortisol administration attenuates 5-HT1A autoreceptor function in humans. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2003, Cambridge, UK: Sage Publications Ltd.
• McAllister-Williams RH, Lockett J. The effect of cortisol administration on the brain potential correlates of false memory in healthy volunteers. In: Biological Psychiatry: 58th Annual Convention and Scientific Program of the Society of Biological Psychiatry. 2003, San Francisco, California, USA: Elsevier Inc.
• McAllister-Williams RH, Garside MJ, Hsu FC. The effect of cortisol on the neural correlates of neuropsychological function [abstract]. Biological Psychiatry 2002, 51(8 (s)), 190S-191S abstract no. 554.
• McAllister-Williams RH, Ferrier IN. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. British Journal of Psychiatry 2002, 180(6), 485-489.
• McAllister-Williams RH, Young AH, Menkes DB. Antidepressant response reversed by interferon [5]. British Journal of Psychiatry 2000, 176, 93.
• McAllister-Williams R, Rugg M. Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval. Psychopharmacology 2002, 160(1), 74-83.
• Alhaj HA, Massey AE, McAllister-Williams RH. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: A double-blind, placebo-controlled study. Psychopharmacology 2006, 188(4), 541-551.
• Alhaj HA, Massey AE, McAllister-Williams RH. A study of the neural correlates of episodic memory and HPA axis status in drug-free depressed patients and healthy controls. Journal of Psychiatric Research 2007, 41(3-4), 295-304.
• McAllister-Williams RH, Massey AE, Fairchild G. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: Evidence for desensitization of the 5-HT1A autoreceptor. Journal of Psychopharmacology 2007, 21(8), 826-832.
• Gallagher P, Leitch MM, Massey AE, McAllister-Williams RH, Young AH. Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: Effects of collection method. Journal of Psychopharmacology 2006, 20(5), 643-649.
• McAllister-Williams RH. Duloxetine in the management of depression. Future Neurology 2006, 1(6), 713-720.
• Young AH, Cookson J, Elliott B, Hellewell JSE, McAllister-Williams RH, Newham J, Ogilvie A, Scott J, Tyrer S, Turner M. Managing the aftermath of mania - Newcastle, 2 September 2005: Consensus Meeting Statement. 2006, Newcastle University: Journal of Psychopharmacology, Sage Publications.
• McAllister-Williams RH. NICE guidelines for the management of depression. British Journal of Hospital Medicine 2006, 67(2), 60-61.
• McAllister-Williams RH, Foran K, Forrest S, Ingram G, McMahon L, Taylor M, Rajwal M, Cornwall L. NICE guidelines on antidepressants. British Journal of General Practice 2006, 56(531), 798-800.
• McAllister-Williams RH. Relapse prevention in bipolar disorder: A critical review of current guidelines. Journal of Psychopharmacology 2006, 20(2), 12-16.
• Mackin P, McAllister-Williams H. Fronto-temporal dementia: remembering images from the past. Neuropsychiatric Disease and Treatment 2005, 1(3), 281-283.
• Massey AE, Marsh VR, McAllister-Williams RH. Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biological Psychology 2004, 65(2), 137-145.
• McAllister-Williams RH, Tyrer SP. Antidepressants for the treatment of depression and anxiety disorders: The same mechanism of action?. In: Kasper, S., den Boer, J.A., Sitsen, J.M.A, ed. Handbook of Depression and Anxiety: A Biological Approach. New York, USA: Informa Healthcare, 2003, pp.443-456.
• McAllister-Williams RH, Watson S. Bipolar disorder ignored by the Mental Health National Service Framework but not forgotten by the British Association for Psychopharmacology. Journal of Psychopharmacology 2003, 17(4), 7-10.
• McAllister-Williams RH, Leech SN. Dermatological syndromes. In: Haddad, P., Dursun, S., Deakin W, ed. Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. Oxford, UK: Oxford University Press, 2003, pp.Chapter 16.
• McAllister-Williams RH, Massey AE. EEG effects of buspirone and pindolol: A method of examining 5-HT1A receptor function in humans. Psychopharmacology 2003, 166(3), 284-293.
• Hsu FC, Garside MJ, Massey AE, McAllister-Williams RH. Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers. Psychopharmacology 2003, 167(4), 431-442.
• Gallagher P, Massey AE, Young AH, McAllister-Williams RH. Effects of acute tryptophan depletion on executive function in healthy male volunteers. BMC Psychiatry 2003, 3(10), 9.
• McAllister-Williams RH, Ferrier IN. Pharmacological management of unipolar and biploar affective disorder. Psychiatry 2003, 5(3), 77-85.
• McAllister-Williams R, Massey A, Rugg M. Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology 2002, 160(4), 434-442.
• McAllister-Williams RH. Mood Disorders. In: Perry, E., Ashton, H.C., Young, A.H, ed. The Neurochemistry of Conciousness. Amsterdam: John Benjamins Publishing Company, 2002, pp.293-308.
• R. H. McAllister-Williams, I. N. Ferrier and A. H. Young. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychological Medicine 1998, 28, 573-584.
• R. H. McAllister-Williams and A. H. Young. Pindolol augmentation of antidepressant therapy. British Journal of Psychiatry 1998, 173, 536-537.
• R. H. McAllister-Williams and A. H. Young. Research assessment exercise - Exercise has implications for clinical academic medicine. British Medical Journal 1998, 316, 1744-1744.
• McAllister-Williams R.H. The definition of primary delusions: Confusion in standard texts and amongst clinicians. Psychiatric Bulletin 1997, 21(6), 346-349.
• R. H. McAllisterWilliams and I. N. Ferrier. Neuroleptic prescribing in residents of nursing homes - Dangerous to extrapolate local audit findings. British Medical Journal 1996, 312, 1667-1667.
• Alhaj HA, Selman M, Jervis V, Rodgers J, Barton S, McAllister-Williams RH. Effect of low-dose acute tryptophan depletion on the specificity of autobiographical memory in healthy subjects with a family history of depression. Psychopharmacology 2012, 222(2), 285-292.
• Sparshatt A, Baldwin DS, Bazire S, Haddad PM, Weston E, McAllister-Williams RH, Taylor D. A naturalistic evaluation and audit database of agomelatine (NEVADA): Clinical outcome at eighteen months. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2011, Harrogate: Sage Publications Ltd.
• Alhaj H, Wisniewski G, McAllister-Williams RH. The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants. Journal of Psychopharmacology 2011, 25(9), 1175-1191.
• McAllister-Williams RH. Translating MDD trial-based evidence into clinical practice. In: European Neuropsychopharmacology: 24th Congress Meeting of European College of Neuropsychopharmacology. 2011, Paris, France: Elsevier BV.
• Hsu FC, McAllister-Williams RH. Effects of repeated cortisol administration on the neural correlates of error processing. In: Journal of Psychopharmacology: Summer Meeting of the British Association for Psychopharmacology. 2002, Harrogate: Sage Publications Ltd.
• McAllister-Williams RH, Massey AE. Buspirone and pindolol effects on the EEG frequency spectrum in healthy men. In: Biological Psychiatry. 2001, Elsevier Inc.
• McAllister-Williams RH, Anderson AJ, Young AH. Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice. International Journal of Neuropsychopharmacology 2001, 4(1), 1-8.
• Porter RJ, McAllister-Williams RH, Young AH. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers. Psychopharmacology 1999, 146(2), 194-198.
• Gallagher P, Nilsson J, Finkelmeyer AE, Goshawk M, Macritchie KA, Lloyd AJ, Thompson JM, Porter RJ, Young AH, Ferrier IN, McAllister-Williams RH, Watson S. Neurocognitive intra-individual variability in mood disorders: effects on attentional response time distributions. Psychological Medicine 2015, 45(14), 2985-2997.
• Moriarty AS, Bradley AJ, Anderson KN, Watson S, Gallagher P, McAllister-Williams RH. Cortisol awakening response and spatial working memory in man: a U-shaped relationship. Human Psychopharmacology: Clinical & Experimental 2014, 29(3), 295-298.
• Symonds CS, McKie S, Elliott R, McAllister-Williams RH, Ferrier IN, Deakin JFW, Anderson I. Emotional and Working Memory in Treatment Resistant Depression: An fMRI Study. In: Society of Biological Psychiatry 69th Annual Scientific Meeting. 2014, New York, USA: Elsevier.
• McAllister-Williams RH, Alhaj HA, Massey A, Pankiv J, Reckermann U. Somatodendritic 5-hydroxytryptamine_1A (5-HT_1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone. Psychological Medicine 2014, 44(4), 767-777.
• Adams T, Khosla E, Walker C, Hanson A, McAllister-Williams RH. WithdrawnA Longitudinal Assessment of the Effect of Citalopram on Emotional Processing in Healthy Subjects. In: Society of Biological Psychiarty 69th Annual Scientific Convention. 2014, New York, USA: Elsevier.
• Sparshatt A, McAllister Williams RH, Baldwin DS, Haddad PM, Bazire S, Weston E, Taylor P, Taylor D. A naturalistic evaluation and audit database of agomelatine: clinical outcome at 12 weeks. Acta Psychiatrica Scandinavica 2013, 128(3), 203-211.
• Yates SJ, Gretenkord S, Hanson A, Taylor L, McAllister-Williams RH. Correlation Between Ability to Potentiate Visual Evoked Potentials and Memory Performance in Healthy Subjects. In: Society of Biological Psychiatry 68th Annual Scientific Convention and Meeting. 2013, San Francisco, CA, USA: Elsevier.
• Nutt DJ, McAllister-Williams RH. Noradrenaline - the forgotten amine?. Journal of Psychopharmacology 2013, 27(8), 657-658.
• Adams T, Hanson A, Pounder Z, Preston S, Gallager P, McAllister-Williams RH. Performing Multiple Neuropsychological Tasks Containing Emotional Stimuli. In: Society of Biological Psychiatry 68th Annual Scientific Convention and Meeting. 2013, San Francisco, CA, USA: Elsevier.
• McAllister-Williams RH, Alhaj AH, Massey A, Pankiv J, Reckermann U. Somatodendritic 5-hydroxytryptamine_1A (5-HT_1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone. Psychological Medicine 2013, n/a, n/a.
• McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, House AO, Hughes T, Lloyd AJ, McColl EMM, Pearce SHS, Siddiqi N, Sinha B, Speed C, Steen IN, Wainwright J, Watson S, Winter FH, Ferrier IN. Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). BMC Psychiatry 2013, 13, 205.
• Kingdon DG, Solomka B, McAllister-Williams H, Turkington D, Gregoire A, Elnazer H, Thagadur M, Hansen L, Rathod S, Gleeson S, Zoha M, Singh P, Naeem F. Care clusters and mental health Payment by Results. British Journal of Psychiatry 2012, 200(2), 162-162.
• McAllister-Williams RH. Depression: From Psychopathology to Pharmacotherapy. British Journal of Psychiatry 2012, 200(2), 168-168.
• Robinson LJ, Stevens LH, Threapleton CJD, Vainiute J, McAllister-Williams RH, Gallagher P. Effects of intrinsic and extrinsic motivation on attention and memory. Acta Psychologica 2012, 141(2), 243-249.
• Moriarty A, Anderson K, Gallagher P, McAllister-Williams RH. Neuropsychological effects of sleep disturbance in healthy subjects. In: Journal of Neurology, Neurosurgery and Psychiatry: Association of British Neurologists Annual Meeting. 2012, Gateshead, UK: BMJ Group.
• Yates SJ, Ahuja N, Gartside SE, McAllister-Williams RH. Serotonin Syndrome following Introduction of Venlafaxine following Withdrawal of Phenelzine: Implications for Drug Washout Periods. Therapeutic Advances in Psychopharmacology 2011, 1(4), 125-127.
• McAllister-Williams RH. Misinterpretation of randomized trial evidence: do antidepressants work?. BRITISH JOURNAL OF HOSPITAL MEDICINE 2008, 69(5), 246-247.
• Mackin P, McAllister-Williams H. Schizophrenia and increased risk of cardiovascular disease. American Heart Journal 2006, 151(5), e13.
• McAllister-Williams RH. Antidepressants for old people - Lack of evidence of efficacy is not evidence of lack of efficacy. British Medical Journal 1999, 319(7213), 849-850.
• McAllister-Williams RH, Man MS, Young AH. Effects of adrenalectomy on 8-OH-DPAT induced hypothermia in mice. Psychopharmacology 1999, 142(1), 73-77.
• Porter RJ, McAllister-Williams RH, Jones S, Young AH. Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion. Psychopharmacology 1999, 143(1), 64-71.
• Porter RJ, McAllister-Williams RH, Lunn BS, Young AH. 5-hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone. Psychopharmacology 1998, 139(3), 243-250.
• McAllister-Williams RH, Ferrier IN, Young AH. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychological Medicine 1998, 28, 573-584.
• Patel MX, Sethi FN, With co-authors (in alphabetical order), Barnes TRE, Dix R, Dratcu L, Fox B, Garriga M, Haste JC, Kahl KG, Lingford-Hughes A, McAllister-Williams H, O'Brien A, Parker C, Paterson B, Paton C, Posporelis S, Taylor DM, Vieta E, Vollm B, Wilson-Jones C, Woods L. Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation. Journal of Psychopharmacology 2018, 32(6), 601-640.
• McAllister-Williams RH, Christmas DMB, Cleare AJ, Currie A, Gledhill J, Insole L, Malizia AL, McGeever M, Morriss R, Robinson LJ, Scott M, Stokes PRA, Talbot PS, Young AH. Multiple-therapy-resistant major depressive disorder: A clinically important concept. British Journal of Psychiatry 2018, 212(5), 274-278.
• Smulders TV, Black-Dominique A, Choudhury TS, Constantinescu SE, Foka K, Walker TJ, Dick K, Bradwell S, McAllister-Williams RH, Gallagher P. A Real-world What-Where-When memory test. Journal of Visualized Experiments 2017, (123), e55646.
• McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH. Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists. Journal of Affective Disorders 2017, 207, 346-352.
• Mcallister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, McDonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. Journal of Psychopharmacology 2017, 31(5), 519-552.
• McAllister-Williams RH, Bones K, Goodwin GM, Harrison J, Katona C, Rasmussen J, Strong S, Young AH. Erratum to “Analysing UK clinicians’ understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists” [J. Affect. Disord. 207 (2017) 346–352] (S0165032716307091) (10.1016/j.jad.2016.09.036). Journal of Affective Disorders 2017, 217, 306-307.
• Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): A multicentre, double-blind, randomised, parallel-group, superiority trial. The Lancet Psychiatry 2017, 4(5), 365-377.
• Bradley AJ, Webb-Mitchell R, Hazu A, Slater N, Middleton B, Gallagher P, McAllister-Williams H, Anderson KN. Sleep and circadian rhythm disturbance in bipolar disorder. Psychological Medicine 2017, 47(9), 1678-1689.
• Marwood l, Taylor R, Goldsmith K, Romeo R, Holland R, Pickles A, Hutchinson J, Dietch D, Cipriani A, Nair R, Attenburrow MJ, Young AH, Geddes J, McAllister-Williams RH, Cleare AJ. Study Protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of Lithium and quetiapine augmentation in treatment resistant depression (the LQD study). BMC Psychiatry 2017, 17, 231.
• Finkelmeyer A, Nilsson J, He J, Stevens L, Maller JJ, Moss RA, Small S, Gallagher P, Coventry K, Ferrier IN, McAllister-Williams RH. Altered hippocampal function in major depression despite intact structure and resting perfusion. Psychological Medicine 2016, 46(10), 2157-2168.
• McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HCR, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BNP, Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S, ADD Study Team. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial. The Lancet Psychiatry 2016, 3(2), 117-127.
• Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vazquez G, Baldacara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Moller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Hidalgo-Mazzei D, Passamar M, Messer T, Bernardo M, Vieta E. Assessment and management of agitation in psychiatry: Expert consensus. World Journal of Biological Psychiatry 2016, 17(2), 86-128.
• McAllister-Williams RH. EEGs and ERPs in bipolar disorders. In: Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition. Cambridge: Cambridge University Press, 2016, pp.130-143.
• Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes TRH, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S, Hunt N, Jones I, Macmillan IC, McAllister-Williams H, Miklowitz DR, Morriss R, Munafo M, Paton C, Saharkian BJ, Saunders KEA, Sinclair J, Taylor D, Vieta E, Young AH. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2016, 30(6), 495-553.
• Adams T, Pounder Z, Preston S, Hanson A, Gallagher P, Harmer CJ, McAllister-Williams RH. Test-retest reliability and task order effects of emotional cognitive tests in healthy subjects. Cognition and Emotion 2016, 30(7), 1247-1259.
• Nilsson J, Thomas AJ, Stevens LH, McAllister-Williams RH, Ferrier IN, Gallagher P. The interrelationship between attentional and executive deficits in major depressive disorder. Acta Psychiatrica Scandinavica 2016, 134(1), 73-82.
• Smart C, Strathdee G, Watson S, Murgatroyd C, McAllister-Williams RH. Early life trauma, depression and the glucocorticoid receptor gene - an epigenetic perspective. Psychological Medicine 2015, 45(16), 3393-3410.
• Olsen K, Howel D, Barber R, Ford GA, Gallagher P, McAllister-Williams RH, Nilsson J, O'Brien J, Parker J, Thomas A. Lessons from a pilot and feasibility randomised trial in depression (Blood pressure Rapid Intensive Lowering And Normal Treatment for Mood and cognition in persistent depression (BRILiANT mood study)). Pilot and Feasibility Studies 2015, 1(44).
• Haddad PM, Talbot PS, Anderson IM, McAllister-Williams RH. Managing inadequate antidepressant response in depressive illness. British Medical Bulletin 2015, 115(1), 183-201.
• Trevithick L, McAllister-Williams RH, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Ellwell C, Hayden K, Holland F, Karim S, Lowe J, Loo C, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, Anderson IM. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study). BMC Psychiatry 2015, 15, 257.